A Plasma Pyrophosphate Cutoff Value for Diagnosing Pseudoxanthoma Elasticum

Area of Science:

• Genetics and Rare Diseases
• Biochemistry and Diagnostics
• Vascular Health

Background:

• Pseudoxanthoma elasticum (PXE) is a rare inherited disorder affecting connective tissues, often leading to peripheral arterial calcification.
• Current PXE diagnosis relies on clinical scoring and genetic analysis, which can be complex and time-consuming.
• Reduced plasma inorganic pyrophosphate ([PPi]p) concentration has been previously associated with PXE.

Purpose of the Study:

• To validate a novel, accurate method for measuring plasma inorganic pyrophosphate ([PPi]p) in a large cohort of PXE patients.
• To determine a reliable cutoff value for [PPi]p to aid in the diagnosis of PXE.
• To establish plasma PPi quantification as a potential blood-based diagnostic assay for PXE.

Main Methods:

• Plasma samples and clinical data were collected from 153 PXE patients and 46 non-PXE individuals at two French reference centers.
• A new method combining enzymatic and ion chromatography approaches was employed to measure plasma PPi concentrations.
• Receiver Operating Characteristic (ROC) analysis was used to determine the optimal PPi cutoff value for PXE diagnosis based on sensitivity and specificity.

Main Results:

• PXE patients exhibited significantly lower plasma PPi levels (0.92 ± 0.30 µmol/L) compared to non-PXE individuals (1.61 ± 0.33 µmol/L, p < 0.0001).
• A plasma PPi cutoff of 1.2 µmol/L demonstrated high diagnostic accuracy (AUC = 0.93), with 83.3% sensitivity and 91.1% specificity for PXE.
• In patients under 50 years old, the PPi cutoff of 1.2 µmol/L yielded even higher accuracy (93% sensitivity, 96% specificity, AUC = 0.97).

Conclusions:

• Quantifying plasma inorganic pyrophosphate ([PPi]p) is a highly accurate method for diagnosing Pseudoxanthoma elasticum (PXE).
• This study introduces the first blood assay for PXE diagnosis, utilizing a specific PPi cutoff value.
• The findings support the clinical utility of plasma PPi measurement for improving the early and accurate diagnosis of PXE.